Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score

BJU International

Volumn 98, Issue 2, 2006, Pages 445-451

  Lam, John S ^a   Seligson, David B ^a   Yu, Hong ^a   Li, Ai ^a   Eeva, Mervi ^a   Pantuck, Allan J ^a   Zeng, Gang ^a   Horvath, Steve ^a   Belldegrun, Arie S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Flap endonuclease 1; Gleason grade; Prostate cancer; Tissue microarray; Tumour markers

Indexed keywords

FLAP ENDONUCLEASE; FLAP ENDONUCLEASE 1; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; SCORING SYSTEM;

AGED; COHORT STUDIES; FLAP ENDONUCLEASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745712501     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06224.x     Document Type: Article

References (46)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
2. Hernandez J, Thompson IM. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 2004; 101: 894-904
3. Tso CL, McBride WH, Sun J et al. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Cancer J 2000; 6: 220-33
4. Patel BJ, Pantuck AJ, Zisman A et al. CL1-GFP: an androgen independent metastatic tumor model for prostate cancer. J Urol 2000; 164: 1420-5
5. Freedland SJ, Pantuck AJ, Paik SH et al. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system. Prostate 2003; 55: 299-307
6. Liu Y, Kao HI, Bambara RA. Flap endonuclease 1: a central component of DNA metabolism. Annu Rev Biochem 2004; 73: 589-615
7. Klungland A, Lindahl T. Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1). EMBO J 1997; 16: 3341-8
8. Prasad R, Dianov GL, Bohr VA, Wilson SH. FEN1 stimulation of DNA polymerase beta mediates an excision step in mammalian long patch base excision repair. J Biol Chem 2000; 275: 4460-6
9. Harrington JJ, Lieber MR. The characterization of a mammalian DNA structure-specific endonuclease. EMBO J 1994; 13: 1235-46
10. Bae SH, Bae KH, Kim JA, Seo YS. RPA governs endonuclease switching during processing of Okazaki fragments in eukaryotes. Nature 2001; 412: 456-61
11. Ruggiero BL, Topal MD. Triplet repeat expansion generated by DNA slippage is suppressed by human flap endonuclease 1. J Biol Chem 2004; 279: 23088-97
12. Rumbaugh JA, Henricksen LA, DeMott MS, Bambara RA. Cleavage of substrates with mismatched nucleotides by Flap endonuclease-1. Implications for mammalian Okazaki fragment processing. J Biol Chem 1999; 274: 14602-8
13. Zheng L, Zhou M, Chai Q et al. Novel function of the flap endonuclease 1 complex in processing stalled DNA replication forks. EMBO Rep 2005; 6: 83-9
14. Christmann M, Tomicic MT, Origer J, Kaina B. Fen1 is induced p53 dependently and involved in the recovery from UV-light-induced replication inhibition. Oncogene 2005; 24: 8304-13
15. Fleming ID, Cooper JS, Hensen DE, Hutter RVP, Kennedy BJ, Murphy GP. AJCC Cancer Staging Manual, 5th edn. Philadelphia: Lippincott-Raven, 1997
16. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58-64
17. Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844-7
18. Harrell FE. Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer Publishing, 2001
19. Lindahl T, Gally JA, Edelman GM. Deoxyribonuclease IV: a new exonuclease from mammalian tissues. Proc Natl Acad Sci USA 1969; 62: 597-603
20. Lieber MR. The FEN-1 family of structure-specific nucleases in eukaryotic DNA replication, recombination and repair. Bioessays 1997; 19: 233-40
21. Tishkoff DX, Filosi N, Gaida GM, Kolodner RD. A novel mutation avoidance mechanism dependent on S. cerevisiae RAD27 is distinct from DNA mismatch repair. Cell 1997; 88: 253-63
22. Kaiser MW, Lyamicheva N, Ma W et al. A comparison of eubacterial and archaeal structure-specific 5′-exonucleases. J Biol Chem 1999; 274: 21387-94
23. Henneke G, Friedrich-Heineken E, Hubscher U. Flap endonuclease 1: a novel tumour suppresser protein. Trends Biochem Sci 2003; 28: 384-90
24. Wu X, Wilson TE, Lieber MR. A role for FEN-1 in nonhomologous DNA end joining: the order of strand annealing and nucleolytic processing events. Proc Natl Acad Sci USA 1999; 96: 1303-8
25. Wu X, Li J, Li X, Hsieh CL, Burgers PM, Lieber MR. Processing of branched DNA intermediates by a complex of human FEN-1 and PCNA. Nucleic Acids Res 1996; 24: 2036-43
26. Chen U, Chen S, Saha P, Dutta A. p21Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex. Proc Natl Acad Sci USA 1996; 93: 11597-602
27. Warbrick E, Lane DP, Glover DM, Cox LS. Homologous regions of Fen1 and p21Cip1 compete for binding to the same site on PCNA: a potential mechanism to co-ordinate DNA replication and repair. Oncogene 1997; 14: 2313-21
28. Vispe S, Ho EL, Yung TM, Satoh MS. Double-strand DNA break formation mediated by flap endonuclease-1. J Biol Chem 2003; 278: 35279-85
29. Gary R, Ludwig DL, Cornelius HL, MacInnes MA, Park MS. The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA-binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21. J Biol Chem 1997; 272: 24522-9
30. Habraken Y, Sung P, Prakash L, Prakash S. A conserved 5′ to 3′ exonuclease activity in the yeast and human nucleotide excision repair proteins RAD2 and XPG. J Biol Chem 1994; 269: 31342-5
31. Kim IS, Lee MY, Lee IH, Shin SL, Lee SY. Gene expression of flap endonuclease-1 during cell proliferation and differentiation. Biochim Biophys Acta 2000; 1496: 333-40
32. Kucherlapati M, Yang K, Kuraguchi M et al. Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression. Proc Natl Acad Sci USA 2002; 99: 9924-9
33. Bambara RA, Murante RS, Henricksen LA. Enzymes and reactions at the eukaryotic DNA replication fork. J Biol Chem 1997; 272: 4647-50
34. Waga S, Stillman B. The DNA replication fork in eukaryotic cells. Annu Rev Biochem 1998; 67: 721-51
35. Otto CJ, Almqvist E, Hayden MR, Andrew SE. The 'flap' endonuclease gene FEN1 is excluded as a candidate gene implicated in the CAG repeat expansion underlying Huntington disease. Clin Genet 2001; 59: 122-7
36. Warbrick E, Coates PJ, Hall PA. Fen1 expression: a novel marker for cell proliferation. J Pathol 1998; 186: 319-24
37. Chen KH, Yakes FM, Srivastava DK et al. Up-regulation of base excision repair correlates with enhanced protection against a DNA damaging agent in mouse cell lines. Nucleic Acids Res 1998; 26: 2001-7
38. Liotta LA, Espina V, Mehta AI et al. Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003; 3: 317-25
39. Hiraoka LR, Harrington JJ, Gerhard DS, Lieber MR, Hsieh CL. Sequence of human FEN-1, a structure-specific endonuclease, and chromosomal localization of the gene (FEN1) in mouse and human. Genomics 1995; 25: 220-5
40. Sato M, Girard L, Sekine I et al. Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer. Oncogene 2003; 22: 7243-6
41. Lam JS, Leppert JT, Vemulapalli SN, Shvarts O, Belldegrun AS. Secondary hormonal therapy for advanced prostate cancer. J Urol 2006; 175: 27-34
42. Tannock IF, de Wit R, Berry WR et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004; 351: 1502-12
43. Petrylak DP, Tangen CM, Hussain MH et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004; 351: 1513-20
44. Morris MJ, Scher HI. Novel strategies and therapeutics for the treatment of prostate carcinoma. Cancer 2000; 89: 1329-48
45. Tumey LN, Huck B, Gleason E et al. The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitors. Bioorg Med Chem Lett 2004; 14: 4915-8
46. Tumey LN, Bom D, Huck B et al. The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors. Bioorg Med Chem Lett 2005; 15: 277-81